Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential-Reference-Cited by-同舟云学术

Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential

Published:2020-06-21 Issue:8 Volume:29 Page:763-770
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Brandts Julia¹²,Ray Kausik K.²

Affiliation:

1. Department of Medicine I, University Hospital RWTH Aachen , Aachen, Germany

2. Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London , London, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1778668

Reference41 articles.

1. World Health Organization . Cardiovascular diseases (CVDs) fact sheet. 2017 [cited 2020 Mar 17 ]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

2. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary

4. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

5. Individual trends in LDL-C control in patients with previous myocardial infarction

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATP-Citrate Lyase (ACLY): An Extensive Investigation from Molecular Insight to Therapeutic implications;Natural Resources for Human Health;2024-06-05

2. Lipid-lowering therapies in patients undergoing percutaneous coronary intervention;Vessel Plus;2024-04-08

3. Lipid-lowering therapies in patients undergoing percutaneous coronary intervention;Vessel Plus;2024-04-08

4. PCSK9 inhibitors: a patent review 2018-2023;Expert Opinion on Therapeutic Patents;2024-04-02

5. Research Progress in the Clinical Treatment of Familial Hypercholesterolemia;Current Medicinal Chemistry;2024-03